Home > Insider Trading > Filing (0001209191-10-018088)

Filing Details

Accession Number:: 0001209191-10-018088
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-03-19 13:00:00
Reporting Period:: 2010-03-18

Filing Date:: 2010-03-19
Accepted Time:: 2010-03-19 21:52:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1339455	Somaxon Pharmaceuticals Inc.	SOMX	Pharmaceutical Preparations (2834)	200161599

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1346901	Jeffrey Raser	Somaxon Pharmaceuticals, Inc. 3830 Valley Centre Drive, Suite 705-461 San Diego CA 92130	Senior Vp, Sales And Marketing	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2010-03-18	7,770	$6.56	19,730	No	4	S	Direct
Common Stock	Disposition	2010-03-18	2,400	$7.81	17,330	No	4	S	Direct
Common Stock	Disposition	2010-03-18	2,100	$8.84	15,230	No	4	S	Direct
Common Stock	Disposition	2010-03-18	230	$9.75	15,000	No	4	S	Direct
Common Stock	Acquisiton	2010-03-18	40,000	$1.17	55,000	No	4	M	Direct
Common Stock	Disposition	2010-03-18	24,500	$6.57	30,500	No	4	S	Direct
Common Stock	Disposition	2010-03-18	7,500	$7.84	23,000	No	4	S	Direct
Common Stock	Disposition	2010-03-18	6,800	$8.82	16,200	No	4	S	Direct
Common Stock	Disposition	2010-03-18	1,200	$9.74	15,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2010-03-18	40,000	$0.00	40,000	$1.17

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
60,000		2019-07-15	No	4	M	Direct

Footnotes

This sale was effected by the reporting person pursuant to a pre-planned selling program under Rule 10b5-1 adopted by the reporting person in 2009.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $6.25 to $7.19 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.30 to $8.28 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $8.46 to $9.2256 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $9.735 to $9.88 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $6.25 to $7.23 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.34 to $8.28 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $8.44 to $9.2256 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Fifty percent of the shares of Common Stock subject to this grant vested on March 18, 2010 and the remaining shares will vest and become exercisable upon the Company's consummation of a strategic collaboration relating to Silenor that is approved by the Board of Directors, subject to Reporting Person's continued service to the Company through such vesting date.
Not applicable.